MetaCap

Quince Therapeutics Insider Trades

NASDAQ: QNCXHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

31.73+2.37 (+8.07%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
0 · $0
Sales
1 · $173.50K
Shares bought / sold
0 / 50.00K
Net activity
Net selling $173,500

Quince Therapeutics insider activity

Over the last 12 months, Quince Therapeutics insiders reported 5 transactions on SEC Form 4: 0 open-market purchases and 1 sale. Insiders bought $0 and sold $173,500 worth of stock, for net insider selling of $173,500. The largest seller was Benatti Luca, with $173,500 in reported sales.

The most recent filing shows Benatti Luca (Director) selling 50,000 shares at $3.47 on Dec 26, 2025. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put QNCX's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

QNCX insider transactions

Quince Therapeutics insider transactions
DateInsiderTypeSharesValueFiling
Dec 26, 2025Benatti LucaDirectorSale50,000$173.50KForm 4
Dec 10, 2025Thye DirkCEO and CMOGift739,885—Form 4
Dec 10, 2025Thye DirkCEO and CMOGift739,885—Form 4
Dec 5, 2025Hannah BrendanCBO, COO & CCOOption exercise25,280$23.76KForm 4
Dec 5, 2025Hannah BrendanCBO, COO & CCOOption exercise2,271$1.25KForm 4
Jun 18, 2025Thye DirkCEO and CMOAward150,944$181.13KForm 4
Jun 18, 2025Ryan Charles S.PresidentAward7,548$9.06KForm 4
Jun 18, 2025Hannah BrendanCBO, COO & CCOAward37,736$45.28KForm 4
Oct 23, 2024Benatti LucaDirectorother8,918—Form 4
Aug 30, 2024Thye DirkCEO AND CHIEF MEDICAL OFFICERBuy77,000$53.90KForm 4
Aug 29, 2024Thye DirkCEO AND CHIEF MEDICAL OFFICERBuy77,500$53.48KForm 4
Aug 21, 2024Hannah BrendanCHIEF BUSINESS OFFICER AND COOBuy23,565$14.85KForm 4
Aug 21, 2024Hannah BrendanCHIEF BUSINESS OFFICER AND COOBuy5,000$3.10KForm 4
Aug 21, 2024Hannah BrendanCHIEF BUSINESS OFFICER AND COOBuy2,280$1.39KForm 4
Aug 20, 2024Hannah BrendanCHIEF BUSINESS OFFICER AND COOBuy3,424$2.05KForm 4
Aug 20, 2024Hannah BrendanCHIEF BUSINESS OFFICER AND COOBuy2,500$1.52KForm 4
Aug 20, 2024Ryan Charles S.PRESIDENTBuy48,387$31.45KForm 4
Aug 19, 2024Hannah BrendanCHIEF BUSINESS OFFICER AND COOBuy2,155$1.25KForm 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related